In this well-designed review, and taking NSCLC as an example, the authors discussed in some detail the various components of the PI3K/AKT/mTOR signaling pathway and described their functions in driving carcinogenesis and the suppression of antitumor activity. This evidence concerns the gene MTOR and non-small cell lung carcinoma.